Chris Lyons is Ortho Spine Partners Chief Commercial Officer. Mr. Lyons is a vital component of any client’s project as he helps create and guide the overall strategy and works on client’s behalf during possible transaction discussions.
Mr. Lyons career began at Smith and Nephew in 1989. While at SNN, he held numerous marketing roles, driving product launches, engaging surgeons, and creating intellectual property predominantly in the companies Knee and Hip product lines. Additionally, he spent two years in the Smith and Nephew Sales Force to learn the underpinnings of what made the organization successful.
In 2005, Chris joined Medtronic Spine and Biologics, with the first three years being focused on driving growth of the International biologics business of Medtronic. The opportunity presented itself to move into the realm of Business Development where he served the past 10 years. During this time, Mr. Lyons worked with all of the executive and cross functional leadership to transact various acquisitions, minority investments, as well as license and distribution agreements. Chris was also selected to join the Board of the Southeast Medical Device Association (SEMDA) of which he remains a contributor, also serving as Chairman of the board for SEMDA for 2016.
The power of Ortho Spine Partners is their leadership. They have developed a game changing business based on integrity and biblical principles to positively influence better outcomes for medical device companies, which in turn has the possibility to influence greater innovation and healthcare delivery to the market in a timely manner. I am excited to be part of this team of industry experts.
With a highly driven, passionate, and entrepreneurial spirit, Chris is excited to be joining the ranks of Ortho Spine Partners as Chief Commercial Officer to assist this growing team of industry experts to influence positive commercialization and exit outcomes for Med Tech and Device companies. Chris will work closely with Venture Capital, Private Equity and other companies focused on successfully exiting. Chris can provide Strategic Guidance, Gap Analysis, M&A consultation and will help implement general strategies that help the shareholders to maximize their return during due diligence and negotiations.